IndraLab

Statements


Oxime inhibits UCHL1. 5 / 5
| 3 2

reach
"LDN-57444 (also referred to as compound 30) is an isatin o-acyl oxime that exhibits active site-directed inhibition of UCHL1 (IC 50 = 0.88 μM) preferentially relative to UCHL3 (IC 50 = 25 μM) [88] ."

reach
"It is, however, quite possible that loss of USP14 protein does not elicit the same effect on cells as inhibition of enzyme activity.LDN-57444 is an isatin O-acyl oxime reported to selectively inhibit [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"LDN-57444 is an isatin O -acyl oxime reported to selectively, competitively, and reversibly inhibit UCHL1 [119] ."

sparser
"Isatin O-acyl oximes efficiently inhibit UCH-L1 and tumor growth in lung cancer cells."
| PMC

sparser
"By utilizing high-throughput screening (HTS) to find inhibitors and traditional medicinal chemistry to optimize their affinity and specificity, we have identified a class of isatin O-acyl oximes that selectively inhibit UCH-L1 as compared to its systemic isoform, UCH-L3."